|RESPONSE TO LETTER TO EDITOR
|Year : 2019 | Volume
| Issue : 4 | Page : 260
Response to letter to editor for: “Lycopodium clavatum for the management of urolithiasis: A randomised double blind placebo controlled trial”
Praveen Oberoi1, Pritha Mehra2
1 Central Council for Research in Homoeopathy, New Delhi, India
2 Dr. D. P. Rastogi Central Research Institute of Homoeopathy, Noida, India
|Date of Submission||09-Dec-2019|
|Date of Acceptance||09-Dec-2019|
|Date of Web Publication||27-Dec-2019|
Dr. Pritha Mehra
Research Officer (H), Dr. D. P. Rastogi Central Research Institute of Homoeopathy, A 1/1, Sector 24, Noida
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Oberoi P, Mehra P. Response to letter to editor for: “Lycopodium clavatum for the management of urolithiasis: A randomised double blind placebo controlled trial”. Indian J Res Homoeopathy 2019;13:260
|How to cite this URL:|
Oberoi P, Mehra P. Response to letter to editor for: “Lycopodium clavatum for the management of urolithiasis: A randomised double blind placebo controlled trial”. Indian J Res Homoeopathy [serial online] 2019 [cited 2020 Jan 26];13:260. Available from: http://www.ijrh.org/text.asp?2019/13/4/260/274025
We are glad to receive your experiences on the use of Lycopodium clavatum and urolithiasis. This empirical and traditional medicine has been used in Homoeopathy with multifactorial action on various diseases. Regarding the article titled 'Lycopodium clavatum for the management of urolithiasis: A randomised double blind placebo controlled trial', we would like to share with you that we could not find the efficacy of Lycopodium in urolithiasis in double-blinded randomised trial, but a positive trend was seen in pain relief.
However, it is to apprise you that in previous studies conducted by the Central Council for Research in Homoeopathy titled 'To Explore the utility of Homoeopathic Medicine Lycopodium clavatum in Urinary Calculi' and 'A Multicentre Observational Study to Ascertain the Role of Homoeopathic Therapy in Urolithiasis', we found Homoeopathy medicine Lycopodium clavatum as effective in the dissolution of stones.
In India, the effect of Lycopodium clavatum has also been explored in preclinical studies as anticancer , and hepatoprotective , medicine. Its pharmacological action in the dissolution of renal stones needs to be further evaluated in future research. We appreciate your efforts in this direction.
We look forward to more exchange of knowledge in the future.
| References|| |
Nayak C, Vikram S, Siddiqui VA, Rupali D. To explore the utility of homoeopathic medicine Lycopodium clavatum
in urinary Calculi. Indian J Res Homoeopath 2010;4:34-43.
Siddiqui VA, Hari S, Jaya G, Nayak C, Vikram S, Sinha MN, et al
. A multicentre observational study to ascertain the role of homoeopathic therapy in urolithiasis. Indian J Res Homoeopath 2011;5:30-9.
Pathak S, Kumar Das J, Jyoti Biswas S, Khuda-Bukhsh AR. Protective potentials of a potentized homeopathic drug, Lycopodium
-30, in ameliorating azo dye induced hepatocarcinogenesis in mice. Mol Cell Biochem 2006;285:121-31.
Samadder A, Das S, Das J, Paul A, Boujedaini N, Khuda-Bukhsh AR. The potentized homeopathic drug, Lycopodium clavatum
(5C and 15C) has anti-cancer effect on hela cells in vitro.
J Acupunct Meridian Stud 2013;6:180-7.
Mandal SK, Biswas R, Bhattacharyya SS, Paul S, Dutta S, Pathak S, et al
. Lycopodine from Lycopodium clavatum
extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. Eur J Pharmacol 2010;626:115-22.
Pathak S, Bhattacharjee N, Das JK, Choudhury SC, Karmakar SR, Banerjee P, et al
. Supportive evidence for the anticancerous potential of alternative medicine against hepatocarcinogenesis in mice. Forsch Komplementmed 2007;14:148-56.